Retour sur lavenir.net
   AZELIS GROUP 11.990 € (+1,18 %)     KBC ANCORA 92.100 € (-0,97 %)     AB INBEV 72.980 € (-1,38 %)     GBL 77.550 € (-0,70 %)     UMICORE 17.760 € (-1,77 %)     ARGENX SE 788.800 € (+0,61 %)     ONWARD MEDICAL 1.890 € (-11,48 %)     NYXOAH 0.780 € (-2,50 %)     BREDERODE 100.000 € (-1,38 %)     SOLVAY 23.460 € (-1,92 %)     D'IETEREN GROUP 177.000 € (-0,34 %)     EVS 18.000 € (+2,74 %)     WDP 19.130 € (-1,39 %)     ASCENCIO 53.500 € (+1,33 %)     RECTICEL 12.180 € (-1,62 %)     BANQUP GROUP 0.800 € (-6,32 %)     CFE 10.850 € (+2,36 %)     OPTION 2.720 € (-5,56 %)     CARE PROPERTY INV. 12.400 € (-0,32 %)     COLRUYT 35.240 € (+0,69 %)     CIE BOIS SAUVAGE 271.000 € (0,00 %)     IBA 16.100 € (-0,25 %)     VAN DE VELDE 29.300 € (0,00 %)     AGFA-GEVAERT 0.389 € (+0,65 %)     SYENSQO 76.800 € (0,00 %)     XIOR 25.000 € (-0,20 %)     AEDIFICA 64.450 € (+0,08 %)     AGEAS 75.800 € (-0,07 %)     BPOST 1.106 € (-2,12 %)     VGP 63.300 € (+1,93 %)     BEKAERT 41.000 € (+0,49 %)     TINC 10.340 € (-0,19 %)     GIMV 49.250 € (-1,50 %)     DECEUNINCK 2.405 € (+0,21 %)     CMB.TECH 15.400 € (-1,79 %)     PROXIMUS 6.060 € (-0,41 %)     WERELDHAVE BELGIUM 50.000 € (-1,19 %)     KINEPOLIS GROUP 48.700 € (-0,41 %)     UCB 276.500 € (-0,58 %)     NEXTENSA 45.550 € (-0,98 %)     DEME GROUP 169.200 € (0,00 %)     ACKERMANS V.HAAREN 266.000 € (-1,34 %)     IMMOBEL 17.650 € (-0,84 %)     LOTUS BAKERIES 13 740.000 € (0,00 %)     ECONOCOM GROUP 1.500 € (+1,35 %)     RETAIL ESTATES 62.300 € (-0,32 %)     SIPEF 110.200 € (-0,36 %)     SOFINA 276.000 € (-3,16 %)     ENERGYVISION 17.840 € (+1,59 %)     ONTEX GROUP 1.558 € (+9,72 %)     ORANGE BELGIUM 22.200 € (-0,45 %)     KBC 113.600 € (-1,09 %)     BIOTALYS 1.920 € (+19,25 %)     JENSEN-GROUP 73.200 € (+0,27 %)     SHURGARD 24.750 € (-2,37 %)     TESSENDERLO 17.380 € (-0,69 %)     TUBIZE-FIN 227.400 € (-0,09 %)     VASTNED 27.200 € (-0,18 %)     INCLUSIO SA/NV 15.150 € (+0,33 %)     HOME INVEST BE. 17.600 € (-0,45 %)  
   SANOFI 80.980 € (+0,43 %)     ASM INTERNATIONAL 720.000 € (+0,25 %)     THEON INTERNAT 29.660 € (0,00 %)     GTT 187.300 € (+1,46 %)     NANOBIOTIX 25.540 € (+0,87 %)     TOTALENERGIES 82.710 € (-1,08 %)     INVENTIVA 3.550 € (+10,08 %)     KERING 180.240 € (+0,32 %)     CSG 14.082 € (-1,14 %)     PHILIPS KON 25.700 € (+4,81 %)     IT LINK 13.700 € (+5,79 %)     BAM GROEP KON 12.710 € (+0,16 %)     L'OREAL 432.700 € (-0,87 %)     ALSTOM 11.125 € (-4,79 %)     CEGEDIM 9.630 € (-0,41 %)     AIRBUS 193.320 € (-1,41 %)     LVMH 401.500 € (+1,99 %)     HEINEKEN HOLDING 77.150 € (-0,58 %)     SCHNEIDER ELECTRIC 239.750 € (-0,29 %)     STELLANTIS NV 4.084 € (-3,68 %)     MAGNUM 17.434 € (-3,27 %)     DANONE 66.020 € (-0,06 %)     ADYEN 827.800 € (-2,75 %)     PROSUS 35.270 € (+0,23 %)     RELX 35.400 € (-1,45 %)     SHELL PLC 46.515 € (-1,23 %)     PHARMING GROUP 1.134 € (+0,98 %)     ORANGE 14.700 € (+1,48 %)     ASML HOLDING 1 385.000 € (-1,63 %)     AXA 43.050 € (+0,19 %)     HEINEKEN 80.840 € (-0,79 %)     STMICROELECTRONICS 43.100 € (-0,27 %)     BUREAU VERITAS 29.150 € (-0,17 %)     EUROCOMMERCIAL 25.000 € (+1,01 %)     HAFFNER ENERGY 0.640 € (+5,96 %)     CRCAM BRIE PIC2CCI 28.140 € (+2,18 %)     BNP PARIBAS ACT.A 87.610 € (+0,65 %)     MAROC TELECOM 8.160 € (0,00 %)     ABN AMRO BANK N.V. 39.770 € (-0,57 %)     AMUNDI 92.600 € (-0,43 %)     TELEPERFORMANCE 80.980 € (-1,34 %)     AKZO NOBEL 61.160 € (-1,26 %)     SWORD GROUP 34.450 € (+0,58 %)     BE SEMICONDUCTOR 156.100 € (+1,69 %)     FLOW TRADERS 22.580 € (-0,53 %)     ICAPE HOLDING 9.800 € (0,00 %)     CTP 12.820 € (+0,79 %)     ADP 114.300 € (-0,44 %)     MEDINCELL 27.840 € (+3,42 %)     VALEO 10.920 € (-3,32 %)     ID LOGISTICS GROUP 372.500 € (+0,40 %)     CREDIT AGRICOLE 15.020 € (+0,54 %)     DASSAULT SYSTEMES 24.980 € (-2,50 %)     PUBLICIS GROUPE SA 101.150 € (+0,15 %)     ING GROEP N.V. 27.715 € (-1,49 %)     CROSSJECT 1.198 € (-4,16 %)     SAFRAN 285.000 € (-1,11 %)     PERNOD RICARD 68.260 € (-0,96 %)     VOPAK 53.150 € (-1,30 %)     GECINA 64.550 € (-1,22 %)  
News Réglementées
09/01/2023 20:00

The Power Play by The Market Herald Releases a New Interview with Algernon Pharmaceuticals Discussing Their Latest News

VANCOUVER, BC / ACCESSWIRE / January 9, 2023 / The Power Play by The Market Herald has announced the release of a new interview with Algernon Pharmaceuticals discussing their latest news.

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Algernon Pharmaceuticals (CSE:AGN) announces upcoming phase 2b chronic cough study of Ifenprodil
The Market Herald, Monday, January 9, 2023, Press release picture

Algernon Pharmaceuticals (AGN) has announced plans for a 180-patient, 90-day Phase 2b clinical study of NP-120 for chronic cough in Q3 of 2023. Following discussions with the U.S. FDA, the company plans to file an investigational new drug (IND) application shortly. Christopher J. Moreau, CEO of Algernon Pharmaceuticals, sat down with Sabrina Cuthbert to discuss the upcoming study.

For the full interview with Christopher J. Moreau and to learn about Algernon Pharmaceuticals, click here.

Interviews for The Power Play by The Market Herald are released daily. To learn more about the companies featured in The Power Play or to explore our other interviews visit The Power Play by The Market Herald.

About The Market Herald

The Market Herald Canada is the leading source of authoritative breaking stock market news for self-directed investors. Our team of Canadian markets reporters, editors and technologists covers the entire listed company universe in Canada. We cover over 3,985 businesses, their people, their investors, and their customers. We write the stories that move the Canadian capital markets.

DISCLAIMER: Report Card Canada Media Ltd. ("Report Card") is a wholly-owned subsidiary of Market Herald Limited, an Australian company ("Market Herald"). Report Card is not an advisory service, and does not offer, buy, sell, or provide any other rating, analysis or opinion on the securities we discuss. We are retained and compensated by the companies that we provide information on to assist them with making information available to the public. All information available on themarketherald.ca and/or this press release should be considered as commercial advertisement and not an endorsement, offer or recommendation to buy or sell securities. Report Card is not registered with any financial or securities regulatory authority in any province or territory of Canada, will not be performing any registerable activity as defined by the applicable regulatory bodies and do not provide nor claim to provide investment advice or recommendations to any visitor of this site or readers of any content on or originating from themarketherald.ca. Market Herald and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Market Herald's affiliates. In such instances, Market Herald and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Market Herald and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize any conflict. All the information on this document and/or the website - themarketherald.ca - is published in good faith and for general information purpose only. Report Card does not make any warranties about the completeness, reliability, and accuracy of this information. Any action you take upon the information you find on this document and/or website (themarketherald.ca) is strictly at your own risk. Report Card will not be liable for any losses and/or damages in connection with the use of our website. From our website, you can visit other websites by following hyperlinks to such external sites. While we strive to provide only quality links to useful and ethical websites, we have no control over the content and nature of these sites. These links to other websites do not imply a recommendation for all the content found on these sites. Site owners and content may change without notice and may occur before we have the opportunity to remove a link which may have gone 'bad'. Please be also aware that when you leave our website, other sites may have different privacy policies and terms which are beyond our control. Please be sure to check the Privacy Policies of these sites as well as their "Terms of Service" before engaging in any business or uploading any information.

CONTACT:
The Market Herald
marketing@themarketherald.ca
themarketherald.ca

SOURCE: The Market Herald



View source version on accesswire.com:
https://www.accesswire.com/734527/The-Power-Play-by-The-Market-Herald-Releases-a-New-Interview-with-Algernon-Pharmaceuticals-Discussing-Their-Latest-News

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière